阿尔法-曼戈斯对急性损伤的脏保护作用:系统性审查和元分析
Moragot Chatatikun1,2, Aman Tedasen1,2, Ratana Netphakdee1
1Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Antioxidants (Basel, Switzerland)
|November 27, 2025
概括
阿尔法-曼戈斯 (AM) 通过减少氧化应激和炎症来保护脏免受急性脏损伤 (AKI) 的承诺. 需要进一步的研究来优化剂量,并将这些发现转化为临床应用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 急性损伤 (AKI) 是一种具有有限治疗选择的危急疾病,通常涉及氧化应激,炎症和亡.
- 阿尔法-曼戈斯 (AM) 是一种天然化合物,具有已知的抗氧化和抗炎性质.
- 对AKI的AM治疗潜力尚未被系统评估.
研究的目的:
- 在急性损伤 (AKI) 模型中对阿尔法-曼戈斯 (AM) 疗效的临床前研究进行系统的审查和元分析.
- 在AKI中评估AM对功能,氧化应激,炎症和亡的关键生物标志物的影响.
- 根据体内和体外证据评估AM的脏保护作用.
主要方法:
- 一个系统的审查和元分析,遵循PRISMA指南,注册在开放科学框架.
- 在PubMed,Scopus,Embase和Web of Science中对AKI模型中的AM研究进行搜索.
- 使用ToxRTool进行数据提取和可靠性评估,重点关注血清肌素,细胞活力,氧化应激标志物,炎症性细胞因子和组织病理学.
主要成果:
- 在AKI模型中,AM显著降低了血清肌素水平,并改善了细胞活力.
- 在AM中,氧化应激标志物 (MDA,ROS) 显著减少,抗氧化酶活性增强 (GSH,GPx,GR,SOD).
- 在体内研究表明,AM降低了炎症性细胞因子 (TNF-α,IL-6) 和改善了脏组织病理,减少了管状缩.
结论:
- 临床前证据强烈支持阿尔法-曼戈斯对急性损伤的脏保护潜力.
- AM有效地减轻氧化应激,炎症和亡,这些都是AKI的关键因素.
- 专注于剂量优化,机制验证和临床试验的进一步研究是有必要的,以转化这些有希望的发现.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
01:22Acute Kidney Injury VI: Nursing Management
371
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
371
01:22Acute Kidney Injury I: Introduction
536
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
536
01:20Acute Kidney Injury V: Interprofessional Care
284
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
01:29Acute Kidney Injury II: Pathophysiology
858
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
858
01:29Acute Kidney Injury III: Clinical Manifestations
785
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
785